Needle-Free Diabetes Care Market Pegged for Robust Expansion During 2016 - 2024
Request for Report Sample: https://www.persistencemarketresearch.com/samples/12388
With an increase in the aging population, prevalence of diabetes population, raise in obese population, and change in food habits are the factors driving the growth of the needle-free diabetes care market during the forecast period. In addition to that, increase in awareness about the diabetes disease conditions are also driving the market. However, incorrect dosage, instances of skin damage or pain, infections, high cost and technical errors might hamper the growth of this needle-free diabetes care market during the forecast period.
Currently very few products are available in the market to treat/diagnose diabetes by using needle-free diabetes care products. Majority of the market is dominated by the conventional needle injections to treat diabetes conditions. However, few companies are launching their products to grab the significant market share. In 2016, Johnson and Johnson is planning to launch their OneTouch Via insulin patch pump in USA and it was also approved by FDA. It is expected to dominate the needle-free diabetes market because it is the only the product which is currently approved by FDA. In the diagnostic services, currently instant glucose monitoring will have the largest market share. However, continuous glucose monitoring might expected to dominate the market during the forecast period owing to detect the prediabetes conditions.
Request for Report TOC: https://www.persistencemarketresearch.com/toc/12388
Based on the end user, Diagnostic centers is expected to have the large market share than the others. This is because of the majorly the diabetes diagnosis tests are usually takes place in the diagnostic centers.
Depending on the geographic region, needle-free diabetes care market is segmented into five key regions: North America, Latin America, Europe, Asia-Pacific and Middle East & Africa. North America is expected to have highest revenue share in needle-free diabetes care market and Asia Pacific geography is expected to dominate the market in future due to increase in the prevalence of diabetes population, especially in China and India.
Some of the key players in needle-free diabetes care market are Anatres pharma, European Pharma Group BV, Johnson and Johnson, Injex UK Ltd, Echo Therapeutics and MannKind Corporation
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Persistence Market Research
7th Floor, New York City,
NY 10007, United States,
USA,Canada Toll Free: 800-961-0353
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Needle-Free Diabetes Care Market Pegged for Robust Expansion During 2016 - 2024 here
News-ID: 1096088 • Views: 288
More Releases from Persistence Market Research
Compression Therapy Devices Market to Exceed CAGR 5.4% by 2017-2025
A recently added report by Persistence Market Research (PMI), titled, “Global Market Study on Compression Therapy: Compression Bandage Expected to be the Most Lucrative Product Type Segment during 2017–2025,” throws light on important aspects of the market. It discusses in-depth the different growth drivers and restraints molding the growth path of the market, its size, and prospects going forward. It unravels the competitive dynamics in the market by leveraging popular
Healthcare Quality Management Market Value Can Reach CAGR 12% by 2017-2022
Healthcare quality management aims to improve the effectiveness of treatments and increase the satisfaction of the patients with the services they are being provided with. For this purpose, various laws have been enacted by the governments all across the world so that the interests of the patients are protected. Healthcare quality management also seeks to reduce the cost of healthcare and reduce the instances of medical errors if not totally
Explore Sickle Cell Disease Treatment Market Set to Achieve CAGR 6.0 % in Reven …
Global sickle cell disease treatment market is expected to witness robust growth during the forecast period. This growth is expected to be primarily driven by increasing adoption of therapies, growing awareness regarding the sickle cell disease treatment in MEA region. “Sickle Cell Disease Treatment Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025)” is the new report published by Persistence Market Research for the projected period of 8-years, i.e. 2017-2025. According
Gardening Tools Market to Witness CAGR of 1.6% Rise in Value Share During the Pe …
In terms of volume, the global gardening tools market is projected to register 1.6% CAGR during the forecast period 2017 to 2025, according to a recent report by Persistence Market Research (PMR). PMR’s report estimates the global sales of gardening tools to expand from nearly 280,000 ‘000 units in 2017 to surpass 300,000 ‘000 units by 2025-end. People in developed economies consider home improvement and small maintenance activities as a favorable
More Releases for Diabetes
Global Diabetes Industry
Global Diabetes Industry Market Insight Global diabetes market is expected to grow at a CAGR of 7.9% percent for the forecasted period of 2016-2021. The market is segmented on the basis of type of diabetes, drugs class and diabetic devices. Diabetic drugs have the highest market share amongst drugs and devices and are also expected to have the highest growth rate with a CAGR of 9%. Some of the top selling
27th European Diabetes Congress
Rising awareness, new technologies and practical approaches within the field of diabetes and endocrine disorders in world’s leading diabetes Conferences One in eight ladies can develop a diabetes disorder throughout her lifespan. And, the amount of individuals affected by diabetes disorders continues to rise every year. However the larger drawback is that almost 60 minutes of those individuals are fully unaware of their condition as well as a way to heal
27th European Diabetes Congress
We would like to invite your team as a Speakers/Delegates. On behalf of Organizing Committee, we take this opportunity in extending a warm and cordial welcome to you to be part of “27th European Diabetes Congress”, held conjointly with multifarious scientific associations, eminent researchers and scholars from all around the globe during June 20-21, 2018 at Rome, Italy. It is an immense pleasure and privilege having you here with us
Global Diabetes Management Devices Market
ReportsWorldwide has announced the addition of a new report title Global Diabetes Management Devices Market to its growing collection of premium market research reports. The global market for diabetes management devices is a substantial, highly competitive market driven by highly sophisticated, evolving technology, particularly in the insulin pump/artificial pancreas and CGM area. The report provides the following useful information: • diabetes overview • key statistics on diabetes prevalence in major regions in the world • medical device product
Non Invasive Diabetes Therapy Market
The role of non-invasive therapy for diabetes market has been on a positive growth path in healthcare industry since 2014. Though the non-invasive therapy concept was brought way back in 1980, the market has not gained much attention leading to development of fewer such devices. DexCom's seven system and Medtronic's Guardian real-time glucose monitoring system are two such products developed and marketed worldwide. The influx of non-invasive therapy has reinforced
Diabetes Gastroparesis Market grows with rising prevalence of diabetes
Diabetes type 1 and type 2 are one of the most common chronic diseases prevalent in the world, affecting millions of people. One of the disorders associated with diabetes type 1 and type 2 is gastroparesis, which is characterized by the delayed emptying of the stomach. One of the major causes of gastroparesis is damage to the vagus nerve, reducing the mobility of the stomach contents. Diabetic neuropathy affects the